Literature DB >> 20711173

Deconvolution of complex G protein-coupled receptor signaling in live cells using dynamic mass redistribution measurements.

Ralf Schröder1, Nicole Janssen, Johannes Schmidt, Anna Kebig, Nicole Merten, Stephanie Hennen, Anke Müller, Stefanie Blättermann, Marion Mohr-Andrä, Sabine Zahn, Jörg Wenzel, Nicola J Smith, Jesús Gomeza, Christel Drewke, Graeme Milligan, Klaus Mohr, Evi Kostenis.   

Abstract

Label-free biosensor technology based on dynamic mass redistribution (DMR) of cellular constituents promises to translate GPCR signaling into complex optical 'fingerprints' in real time in living cells. Here we present a strategy to map cellular mechanisms that define label-free responses, and we compare DMR technology with traditional second-messenger assays that are currently the state of the art in GPCR drug discovery. The holistic nature of DMR measurements enabled us to (i) probe GPCR functionality along all four G-protein signaling pathways, something presently beyond reach of most other assay platforms; (ii) dissect complex GPCR signaling patterns even in primary human cells with unprecedented accuracy; (iii) define heterotrimeric G proteins as triggers for the complex optical fingerprints; and (iv) disclose previously undetected features of GPCR behavior. Our results suggest that DMR technology will have a substantial impact on systems biology and systems pharmacology as well as for the discovery of drugs with novel mechanisms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20711173     DOI: 10.1038/nbt.1671

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  50 in total

Review 1.  Receptors coupled to heterotrimeric G proteins of the G12 family.

Authors:  Natalia A Riobo; David R Manning
Journal:  Trends Pharmacol Sci       Date:  2005-03       Impact factor: 14.819

Review 2.  How many drug targets are there?

Authors:  John P Overington; Bissan Al-Lazikani; Andrew L Hopkins
Journal:  Nat Rev Drug Discov       Date:  2006-12       Impact factor: 84.694

Review 3.  The evasive nature of drug efficacy: implications for drug discovery.

Authors:  Ségolène Galandrin; Geneviève Oligny-Longpré; Michel Bouvier
Journal:  Trends Pharmacol Sci       Date:  2007-07-19       Impact factor: 14.819

4.  Comparing label-free biosensors for pharmacological screening with cell-based functional assays.

Authors:  Matthew F Peters; François Vaillancourt; Madeleine Heroux; Manon Valiquette; Clay W Scott
Journal:  Assay Drug Dev Technol       Date:  2010-04       Impact factor: 1.738

Review 5.  7TM pharmacology measured by label-free: a holistic approach to cell signalling.

Authors:  Magalie Rocheville; Jeff C Jerman
Journal:  Curr Opin Pharmacol       Date:  2009-08-09       Impact factor: 5.547

Review 6.  Agonist-receptor efficacy. II. Agonist trafficking of receptor signals.

Authors:  T Kenakin
Journal:  Trends Pharmacol Sci       Date:  1995-07       Impact factor: 14.819

7.  Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors.

Authors:  Mounia Azzi; Pascale G Charest; Stéphane Angers; Guy Rousseau; Trudy Kohout; Michel Bouvier; Graciela Piñeyro
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-17       Impact factor: 11.205

8.  Discovery of potent and selective agonists for the free fatty acid receptor 1 (FFA(1)/GPR40), a potential target for the treatment of type II diabetes.

Authors:  Elisabeth Christiansen; Christian Urban; Nicole Merten; Kathrin Liebscher; Kasper K Karlsen; Alexandra Hamacher; Andreas Spinrath; Andrew D Bond; Christel Drewke; Susanne Ullrich; Matthias U Kassack; Evi Kostenis; Trond Ulven
Journal:  J Med Chem       Date:  2008-11-27       Impact factor: 7.446

9.  The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation.

Authors:  Christopher M Henstridge; Nariman A B Balenga; Lesley A Ford; Ruth A Ross; Maria Waldhoer; Andrew J Irving
Journal:  FASEB J       Date:  2008-08-29       Impact factor: 5.191

10.  Optical biosensor differentiates signaling of endogenous PAR1 and PAR2 in A431 cells.

Authors:  Ye Fang; Ann M Ferrie
Journal:  BMC Cell Biol       Date:  2007-06-22       Impact factor: 4.241

View more
  101 in total

1.  Signaling pathways: Purinosomes under GPCR control.

Authors:  Klaus Mohr; Evi Kostenis
Journal:  Nat Chem Biol       Date:  2011-11-15       Impact factor: 15.040

2.  Dynamic mass redistribution assays decode surface influence on signaling of endogenous purinergic P2Y receptors.

Authors:  Elizabeth Tran; Haiyan Sun; Ye Fang
Journal:  Assay Drug Dev Technol       Date:  2011-11-08       Impact factor: 1.738

3.  A holistic view of GPCR signaling.

Authors:  Terry Kenakin
Journal:  Nat Biotechnol       Date:  2010-09       Impact factor: 54.908

4.  Differential signaling by splice variants of the human free fatty acid receptor GPR120.

Authors:  Sarah-Jane Watson; Alastair J H Brown; Nicholas D Holliday
Journal:  Mol Pharmacol       Date:  2012-01-26       Impact factor: 4.436

5.  Dynamic ligand binding dictates partial agonism at a G protein-coupled receptor.

Authors:  Andreas Bock; Brian Chirinda; Fabian Krebs; Regina Messerer; Julia Bätz; Mathias Muth; Clelia Dallanoce; Dominika Klingenthal; Christian Tränkle; Carsten Hoffmann; Marco De Amici; Ulrike Holzgrabe; Evi Kostenis; Klaus Mohr
Journal:  Nat Chem Biol       Date:  2013-11-10       Impact factor: 15.040

6.  Pharmacological profiling of sigma 1 receptor ligands by novel receptor homomer assays.

Authors:  Hideaki Yano; Alessandro Bonifazi; Min Xu; Daryl A Guthrie; Stephanie N Schneck; Ara M Abramyan; Andrew D Fant; W Conrad Hong; Amy H Newman; Lei Shi
Journal:  Neuropharmacology       Date:  2018-01-31       Impact factor: 5.250

7.  Label-Free Dynamic Mass Redistribution Reveals Low-Density, Prosurvival α1B-Adrenergic Receptors in Human SW480 Colon Carcinoma Cells.

Authors:  Dorathy-Ann Harris; Ji-Min Park; Kyung-Soon Lee; Cong Xu; Nephi Stella; Chris Hague
Journal:  J Pharmacol Exp Ther       Date:  2017-02-14       Impact factor: 4.030

8.  Identification of determinants required for agonistic and inverse agonistic ligand properties at the ADP receptor P2Y12.

Authors:  Philipp Schmidt; Lars Ritscher; Elizabeth N Dong; Thomas Hermsdorf; Maxi Cöster; Doreen Wittkopf; Jens Meiler; Torsten Schöneberg
Journal:  Mol Pharmacol       Date:  2012-10-23       Impact factor: 4.436

9.  Detection of free fatty acid receptor 1 expression: the critical role of negative and positive controls.

Authors:  Charlott-Amelie Teutsch; Madhura Panse; Manuel Grundmann; Gabriele Kaiser; Evi Kostenis; Hans-Ulrich Häring; Susanne Ullrich
Journal:  Diabetologia       Date:  2014-01-26       Impact factor: 10.122

10.  Agonists with supraphysiological efficacy at the muscarinic M2 ACh receptor.

Authors:  R Schrage; W K Seemann; J Klöckner; C Dallanoce; K Racké; E Kostenis; M De Amici; U Holzgrabe; K Mohr
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.